Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence

Addiction Biology

Volumn 20, Issue 1, 2015, Pages 38-42

  Bell, Richard L ^a   Lopez, Marcelo F ^b   Cui, Changhai ^c   Egli, Mark ^c   Johnson, Kirk W ^d   Franklin, Kelle M ^a   Becker, Howard C ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d MediciNova Inc   (United States)

Author keywords

Alcohol; alcohol dependence; alcohol preference; alcoholism; AV 411; ethanol; ibudilast; MN 166; neuroimmune; phosphodiesterase

Indexed keywords

ALCOHOL; IBUDILAST; NALTREXONE; QUETIAPINE; TOPIRAMATE; PHOSPHODIESTERASE INHIBITOR; PYRIDINE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; MALE; MOUSE; NONHUMAN; RAT; RELAPSE; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECTS;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; MALE; MICE; PHOSPHODIESTERASE INHIBITORS; PYRIDINES; RATS;

EID: 84919845873     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12106     Document Type: Article

References (20)

1. Becker HC, Lopez MF, (2004) Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol Clin Exp Res 28: 1829-1838.
2. Blednov YA, Ponomarev I, Geil C, Bergeson S, Koob GF, Harris RA, (2012) Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict Biol 17: 108-120.
3. Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, Hodsdon ME, Bucala R, Cappello M, Gross M, Gaeta F, Johnson K, Lolis EJ, (2010) Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci U S A 107: 11313-11318.
4. Crews FT, Zou J, Qin L, (2011) Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun 25 (Suppl. 1): S4-S12.
5. Crews FT, Qin L, Sheedy D, Vetreno RP, Zou J, (2013) High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence. Biol Psychiatry 73: 602-612.
6. Egli M, (2005) Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addict Biol 10: 309-319.
7. Frank MG, Watkins LR, Maier SF, (2011) Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav Immun 25 (Suppl. 1): S21-S28.
8. Gibson LC, Hastings SF, McPhee I, Clayton RA, Darroch CE, Mackenzie A, Mackenzie FL, Nagasawa M, Stevens PA, Mackenzie SJ, (2006) The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family. Eur J Pharmacol 538: 39-42.
9. Griffin WC III, Lopez MF, Yanke AB, Middaugh LD, Becker HC, (2009) Repeated cycles of chronic intermittent ethanol exposure increases voluntary ethanol drinking and ethanol concentration in the nucleus accumbens. Psychopharmacology (Berl) 201: 569-580.
10. Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT, Hommer D, Barr CS, (2010) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35: 334-344.
11. Hu W, Lu T, Chen A, Huang Y, Hansen R, Chandler LJ, Zhang HT, (2011) Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology (Berl) 218: 331-339.
12. Kithcart AP, Cox GM, Sielecki T, Short A, Pruitt J, Papenfuss T, Shawler T, Gienapp I, Satoskar AR, Whitacre CC, (2010) A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease. FASEB J 24: 4459-4466.
13. Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW, (2007) Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs 16: 935-950.
14. Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, Falk DE, Moss H, Huebner R, Noronha A, (2012) Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17: 513-527.
15. Qin L, Crews FT, (2012) NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J Neuroinflammation 9: 5.
16. Rimondini R, Arlinde C, Sommer W, Heilig M, (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 16: 27-35.
17. Rolan P, Gibbons JA, He L, Chang E, Jones D, Gross MI, Davidson JB, Sanftner LM, Johnson KW, (2008) Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. Br J Clin Pharmacol 66: 792-801.
18. Rolan P, Hutchinson M, Johnson K, (2009) Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother 10: 2897-2904.
19. Wakita H, Tomimoto H, Akiguchi I, Lin JX, Ihara M, Ohtani R, Shibata M, (2003) Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res 992: 53-59.
20. Wen RT, Zhang M, Qin WJ, Liu Q, Wang WP, Lawrence AJ, Zhang HT, Liang JH, (2012) The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol Clin Exp Res 36: 2157-2167.